List of articles with "Glioblastoma"

LAM561 Trial Update

LAM561 Trial Update

Spain Glioblastoma Laminar Pharma LAM561 Palma de Mallorca
Innovative Glioblastoma Program

Innovative Glioblastoma Program

Canada Montreal Immunotherapy Glioblastoma HDT Bio
Matricelf Milestone

Matricelf Milestone

Israel Tel Aviv Glioblastoma Spinal Cord Injury Matricelf
New Data on DCVax®-L

New Data on DCVax®-L

USA Bethesda Glioblastoma Northwest Biotherapeutics DCVax®-L
DCVax-L Survival Data

DCVax-L Survival Data

United States Bethesda Glioblastoma Northwest Biotherapeutics DCVax-L
Grapes for Glioblastoma

Grapes for Glioblastoma

United States Glioblastoma Santa Barbara nonprofit Folded Hills
New Hope for Glioblastoma

New Hope for Glioblastoma

United States Stamford Glioblastoma GCAR Knoa Pharma
RZ-001 Clinical Data

RZ-001 Clinical Data

South Korea Rznomics RZ-001 Glioblastoma Seongnam
Curasight's uTREAT® Trial Results

Curasight's uTREAT® Trial Results

Denmark Copenhagen Glioblastoma Curasight uTREAT®
Curasight uTREAT® Trial

Curasight uTREAT® Trial

Denmark Copenhagen Glioblastoma Curasight uTREAT
GLIX1 Clinical Trial Update

GLIX1 Clinical Trial Update

Israel Tel Aviv BioLineRx Glioblastoma GLIX1
Lucicebtide Phase 2 Trial

Lucicebtide Phase 2 Trial

USA Glioblastoma Sapience Therapeutics Tarrytown Lucicebtide
Phase 1/2 Trial Begins

Phase 1/2 Trial Begins

USA Jupiter Glioblastoma Myosin Therapeutics MT-125
Diakonos Oncology News

Diakonos Oncology News

United States Houston Glioblastoma Diakonos Oncology DOC1021
Caris Validates AI Insights

Caris Validates AI Insights

USA Caris Life Sciences Irving Glioblastoma AI Insights
ImmunoGenesis Presents at AACR

ImmunoGenesis Presents at AACR

United States San Diego Glioblastoma ImmunoGenesis STING Agonist
Alpheus Medical Trial

Alpheus Medical Trial

United States Alpheus Medical Chanhassen Glioblastoma PoMA
Glioblastoma Therapy Breakthrough

Glioblastoma Therapy Breakthrough

Glioblastoma UP Oncolytics Rosalind Franklin University
BioLineRx GLIX1 Study

BioLineRx GLIX1 Study

Israel Tel Aviv BioLineRx Glioblastoma GLIX1
Myosin Therapeutics at Conferences

Myosin Therapeutics at Conferences

United States Jupiter Glioblastoma Myosin Therapeutics MT-125
Akeso and INOVIO Collaboration

Akeso and INOVIO Collaboration

China Hong Kong Glioblastoma Akeso INOVIO
Unite for Brain Tumor Fund

Unite for Brain Tumor Fund

USA New York Glioblastoma Mark Foundation Sontag Foundation
BRIDGES Trial Launch

BRIDGES Trial Launch

United States Glioblastoma Valhalla, NY GammaTile GT Medical Technologies
Curasight uTREAT Trial

Curasight uTREAT Trial

Denmark Copenhagen Glioblastoma Curasight uTREAT
Innovative Cancer Therapy

Innovative Cancer Therapy

United States Glioblastoma North Chicago UP Oncolytics RFU
Innovative Brain Cancer Study

Innovative Brain Cancer Study

USA Durham Glioblastoma Exvade Bioscience Tumor Monorail
TTX-MC138 Glioblastoma Breakthrough

TTX-MC138 Glioblastoma Breakthrough

USA Boston Glioblastoma TTX-MC138 TransCode Therapeutics
T-MAXIMUM CAR-T Breakthrough

T-MAXIMUM CAR-T Breakthrough

United States Beijing Glioblastoma CAR-T therapy T-MAXIMUM
Curasight's uTREAT Trial

Curasight's uTREAT Trial

Denmark Copenhagen Glioblastoma Curasight uTREAT
Curasight uTREAT Trial

Curasight uTREAT Trial

Denmark Copenhagen Glioblastoma Curasight uTREAT
Curasight Trial Launch

Curasight Trial Launch

Denmark Copenhagen Glioblastoma Curasight uTREAT
Curasight's uTREAT® Trial

Curasight's uTREAT® Trial

Denmark Copenhagen Glioblastoma Curasight uTREAT
Enhancing Glioblastoma Treatment

Enhancing Glioblastoma Treatment

USA Glioblastoma Missoula FYR Bio NuvOx Therapeutics
Preclinical Breakthrough

Preclinical Breakthrough

USA Glioblastoma Vascarta Summit CUNY
FDA Fast Track for MT-125

FDA Fast Track for MT-125

USA Jupiter Glioblastoma Myosin Therapeutics MT-125
Phase I Trial Recruitment

Phase I Trial Recruitment

Australia Glioblastoma Brisbane Cyteph Ltd CYT-101
PNM Receives Orphan Drug Status

PNM Receives Orphan Drug Status

USA Redwood City Glioblastoma FDA Orphan Drug Precision NeuroMed
Glioblastomas' Wide Impact

Glioblastomas' Wide Impact

United States Cancer Research Glioblastoma Bronx Immune Response
Myosin's $4.5M Grant

Myosin's $4.5M Grant

USA Jupiter Glioblastoma Myosin Therapeutics MT-125
GLIX1 FDA Clearance

GLIX1 FDA Clearance

Glioblastoma Norway Oslo GLIX1 Hemispherian
DOC1021 Phase 2 Trial

DOC1021 Phase 2 Trial

USA Los Angeles Glioblastoma Diakonos Oncology DOC1021
Innovating Glioblastoma Treatment

Innovating Glioblastoma Treatment

USA Palo Alto Glioblastoma SandboxAQ iOncologi
Myosin's New Cancer Therapies

Myosin's New Cancer Therapies

USA Jupiter cancer therapies Glioblastoma Myosin Therapeutics
MT-125 Trial Approval

MT-125 Trial Approval

United States Jupiter Glioblastoma Myosin Therapeutics MT-125
Phase I Results of DOC1021

Phase I Results of DOC1021

USA Houston Glioblastoma Diakonos Oncology Dubodencel
Lucicebtide Updates

Lucicebtide Updates

United States Chicago Glioblastoma Sapience Therapeutics Lucicebtide
Diakonos Raises $20 Million

Diakonos Raises $20 Million

United States Houston Immunotherapy Glioblastoma Diakonos Oncology
Diakonos at ASCO 2025

Diakonos at ASCO 2025

United States Glioblastoma Chicago, Illinois Diakonos Oncology DOC1021
Alpheus Medical Fundraise

Alpheus Medical Fundraise

United States Alpheus Medical Sonodynamic Therapy Chanhassen Glioblastoma
Lucicebtide at ASCO 2025

Lucicebtide at ASCO 2025

USA Glioblastoma Sapience Therapeutics Tarrytown Lucicebtide

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.